Study to Evaluate Efficacy, Safety and Tolerability of HM15211 in Subjects
This study is a phase 2 study to Evaluate Efficacy, Safety and Tolerability of HM15211 Treatment for 12 Months in Subjects with Biopsy Confirmed NASH
- Investigator
- Virginia C Clark
- Protocol ID
- NCT04505436
- Ages
- 18 Years – 70 Years
- Sexes
- All
- Location
- Gainesville